Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 35

1.

Association of the DIO2 gene single nucleotide polymorphisms with recurrent depressive disorder.

Gałecka E, Talarowska M, Orzechowska A, Górski P, Bieńkiewicz M, Szemraj J.

Acta Biochim Pol. 2015;62(2):297-302. doi: 10.18388/abp.2015_1002. Epub 2015 Jun 22.

2.

Thiol protein groups correlate with cognitive impairment in patients with recurrent depressive disorder.

Gałecki P, Talarowska M, Bobińska K, Kowalczyk E, Gałecka E, Lewiński A.

Neuro Endocrinol Lett. 2013;34(8):780-6.

PMID:
24522026
3.

Working memory impairment as a common component in recurrent depressive disorder and certain somatic diseases.

Galecki P, Talarowska M, Moczulski D, Bobinska K, Opuchlik K, Galecka E, Florkowski A, Lewinski A.

Neuro Endocrinol Lett. 2013;34(5):436-45.

PMID:
23922050
4.

Vascular endothelial growth factor gene (VEGFA) polymorphisms may serve as prognostic factors for recurrent depressive disorder development.

Gałecki P, Gałecka E, Maes M, Orzechowska A, Berent D, Talarowska M, Bobińska K, Lewiński A, Bieńkiewicz M, Szemraj J.

Prog Neuropsychopharmacol Biol Psychiatry. 2013 Aug 1;45:117-24. doi: 10.1016/j.pnpbp.2013.04.011. Epub 2013 May 11.

PMID:
23673188
5.

Vascular endothelial growth factor receptor 2 gene (KDR) polymorphisms and expression levels in depressive disorder.

Gałecki P, Orzechowska A, Berent D, Talarowska M, Bobińska K, Gałecka E, Lewiński A, Maes M, Szemraj J.

J Affect Disord. 2013 May;147(1-3):144-9. doi: 10.1016/j.jad.2012.10.025. Epub 2012 Nov 17.

PMID:
23164459
6.

Single nucleotide polymorphisms of NR3C1 gene and recurrent depressive disorder in population of Poland.

Gałecka E, Szemraj J, Bieńkiewicz M, Majsterek I, Przybyłowska-Sygut K, Gałecki P, Lewiński A.

Mol Biol Rep. 2013 Feb;40(2):1693-9. doi: 10.1007/s11033-012-2220-9. Epub 2012 Oct 17.

7.

The expression of genes encoding for COX-2, MPO, iNOS, and sPLA2-IIA in patients with recurrent depressive disorder.

Gałecki P, Gałecka E, Maes M, Chamielec M, Orzechowska A, Bobińska K, Lewiński A, Szemraj J.

J Affect Disord. 2012 May;138(3):360-6. doi: 10.1016/j.jad.2012.01.016. Epub 2012 Feb 12.

PMID:
22331023
8.

Single nucleotide polymorphisms and mRNA expression for melatonin MT(2) receptor in depression.

Gałecka E, Szemraj J, Florkowski A, Gałecki P, Bieńkiewicz M, Karbownik-Lewińska M, Lewiński A.

Psychiatry Res. 2011 Oct 30;189(3):472-4. doi: 10.1016/j.psychres.2011.01.021. Epub 2011 Feb 26.

PMID:
21353709
9.

COX-2 expression in papillary thyroid carcinoma (PTC) in cytological material obtained by fine needle aspiration biopsy (FNAB).

Krawczyk-Rusiecka K, Wojciechowska-Durczyńska K, Cyniak-Magierska A, Adamczewski Z, Gałecka E, Lewiński A.

Thyroid Res. 2011 Jan 10;4(1):3. doi: 10.1186/1756-6614-4-3.

10.

Association between inducible and neuronal nitric oxide synthase polymorphisms and recurrent depressive disorder.

Gałecki P, Maes M, Florkowski A, Lewiński A, Gałecka E, Bieńkiewicz M, Szemraj J.

J Affect Disord. 2011 Mar;129(1-3):175-82. doi: 10.1016/j.jad.2010.09.005.

PMID:
20888049
11.

An inducible nitric oxide synthase polymorphism is associated with the risk of recurrent depressive disorder.

Gałecki P, Maes M, Florkowski A, Lewiński A, Gałecka E, Bieńkiewicz M, Szemraj J.

Neurosci Lett. 2010 Dec 17;486(3):184-7. doi: 10.1016/j.neulet.2010.09.048. Epub 2010 Sep 30.

PMID:
20869428
12.

Evaluation of NDRG2 gene expression in primary papillary thyroid carcinoma and in metastases of this neoplasm to regional lymph nodes.

Mordalska A, Latek J, Ferenc T, Pomorski L, Gałecka E, Zygmunt A, Lewiński A.

Thyroid Res. 2010 Aug 30;3(1):6. doi: 10.1186/1756-6614-3-6.

13.

Relative quantification of PIK3CA gene expression level in fine-needle aspiration biopsy thyroid specimens collected from patients with papillary thyroid carcinoma and non-toxic goitre by real-time RT-PCR.

Wojciechowska-Durczyńska K, Krawczyk-Rusiecka K, Cyniak-Magierska A, Zygmunt A, Gałecka E, Lewiński A.

Thyroid Res. 2010 Aug 30;3(1):5. doi: 10.1186/1756-6614-3-5.

14.

Single-nucleotide polymorphisms and mRNA expression for melatonin synthesis rate-limiting enzyme in recurrent depressive disorder.

Gałecki P, Szemraj J, Bartosz G, Bieńkiewicz M, Gałecka E, Florkowski A, Lewiński A, Karbownik-Lewińska M.

J Pineal Res. 2010 May;48(4):311-7. doi: 10.1111/j.1600-079X.2010.00754.x.

PMID:
20433639
15.

Single nucleotide polymorphism of the KIBRA gene in recurrent depressive disorders.

Galecki P, Szemraj J, Florkowski A, Talarowska M, Bienkiewicz M, Galecka E, Lewinski A.

Neuro Endocrinol Lett. 2010;31(1):97-102.

PMID:
20150879
16.

Lipid peroxidation and antioxidant protection in patients during acute depressive episodes and in remission after fluoxetine treatment.

Gałecki P, Szemraj J, Bieńkiewicz M, Florkowski A, Gałecka E.

Pharmacol Rep. 2009 May-Jun;61(3):436-47.

17.

Oxidative stress parameters after combined fluoxetine and acetylsalicylic acid therapy in depressive patients.

Gałecki P, Szemraj J, Bieńkiewicz M, Zboralski K, Gałecka E.

Hum Psychopharmacol. 2009 Jun;24(4):277-86. doi: 10.1002/hup.1014.

PMID:
19319921
18.

[Chosen non-enzymatic substances that participate in a protection against overproduction of free radicals].

Gałecka E, Mrowicka M, Malinowska K, Gałecki P.

Pol Merkur Lekarski. 2008 Sep;25(147):269-72. Review. Polish.

PMID:
19112847
19.

[Antioxidative enzymes--structure, properties, functions].

Gałecka E, Jacewicz R, Mrowicka M, Florkowski A, Gałecki P.

Pol Merkur Lekarski. 2008 Sep;25(147):266-8. Review. Polish.

PMID:
19112846
20.

[The influence of degenerative changes on the production of free radicals and the lipid peroxidation at the patients after alloplasty of the hip joint].

Mrowicka M, Gałecka E, Miller E, Garncarek P.

Pol Merkur Lekarski. 2008 Aug;25(146):145-9. Polish.

PMID:
18942334
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk